UFPT UFP Technologies, Inc. - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$300.70
· of 52w range
· above low
· to high
$173.8652w low
$338.7152w high
Market Cap (MRQ)
$2.33B
P/E (TTM)
32.4
EPS (TTM)
$9.28
Revenue (TTM)
$632M
your badges
52W Range
$174–$339
Analyst Rating
BUY
Price Target
$355
P/E
32.4
ROE
17.1%
Net Profit Margin
11.4%
Your badge strip is empty — pin a metric anywhere on this page.
UFPT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$300.70
Market Cap (MRQ)
$2.33B
P/E (TTM)
32.4
EPS (TTM)
$9.28
Revenue (TTM)
$632M
ROE (TTM)
17.1%
Debt/Equity (MRQ)
0.3
52W Range
$174–$339
UFPT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About UFP Technologies, Inc. - Common Stock Company overview from Wikipedia
UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products.
UFP Technologies manufactures a wide range of single-use medical devices, components, and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
The company also provides highly engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets.
History
1963-1975
United Packaging Corporation was founded in 1963 by William H. Shaw, Robert W. Drew, and Richard L. Bailly in Woburn, MA as a manufacturer of protective packaging, primarily for electronics. In 1964, the company expanded operations and moved its factory headquarters to Georgetown, Massachusetts. In 1967, the company changed its name to United Foam Plastics Corporation to reflect a broader market capability.
1976-1983
In 1976, with a focus on foam fabrication, the company started precision molding cross-linked polyethylene foam components for the military, consumer, and industrial markets.
1984-1993
In 1988 UFP Technologies introduced compression molded medical protective packaging using specialized foams. On December 17, 1993 the company completed its IPO and formally changed its name to UFP Technologies, Inc. Acquisitions brought new, highly specialized materials including various foams, films, and fabrics used in a range of medical, military, aerospace, consumer, and automotive applications. Additionally, UFP added molded pulp packaging to its portfolio through the acquisition of Moulded Fibre Technology out of Portland, ME.
1994-2003
UFP's growing medical customer base prompted its investment in cleanroom production starting in 1994. In 2001 the company introduced thermoplastic polyurethane (TPU) based pouches and bags as an alternative to foam packaging for the orthopedic implant market. Additional acquisitions expanded its medical foams access and capabilities for a range of applications.
2004-2013
UFP continued to focus on the medical market, accounting for 50% of its $100 million revenue by 2008. Between 2008 and 2013, UFP made five acquisitions to continue its foam offering to medical clients. In 2013 the company introduced a new product line called FlexShield®, a TPU based packaging solution for medical devices, instruments, and orthopedic implants.
2014-2024
In 2016 UFP expanded operations and relocated its headquarters to Newburyport, Massachusetts. In 2022 UFP Technologies sold Molded Fiber Business to CKF, Inc.
In 2022 Sales exceeded $300 million and the firm opened a new medical manufacturing operation in Tijuana, Mexico. In 2023, UFP Technologies was added to the S&P SmallCap 600 index. Additional MedTech acquisitions expanded UFP's international footprint to 5 countries and added complete device manufacturing capabilities. As of 2024, its MedTech business accounted for over 90% of revenue.
Acquisitions
1993 - Moulded Fibre Technology
1997 - FCE Industries
1998 - Pacific Foam Technologies
2000 – Simco Industries
2008 - Stephenson & Lawyer
2009 - Advanced Materials Group
2009 - Foamade Industries Inc.
2009 - E.N. Murray
2013 - Packaging Alternatives Corporation
2018 – Dielectrics
2021 - Contech Medical
2021 – DAS Medical
2022 - Advant Medical
2024 - AJR Enterprises
2024 - AQF Medical
2024 - Marble Medical
2024 - Welch Fluorocarbon
2025 - UNIPEC
2025 - Techno Plastics Industries, Inc. (TPI)
Awards & Recognition
The National Association for Business Resources (NABR):
"Best and Brightest Companies to Work for In The Nation" (2024, 2023, 2022, 2021, 2020, and 2018)
"New England's Best & Brightest to Work For" (formerly "Boston's Best & Brightest Companies to Work For") (2024, 2023, 2022, 2021, 2020, and 2018)
"West Michigan's Best & Brightest Companies to Work For" (2024, 2023, 2022, 2021, 2020, 2019 and 2018)
Diversity Jobs' "Top Diversity Employer (2024)
Forbes
"Most Trusted Companies In America" (2025)
"America's Most Successful Small-Cap Companies" (2024, 2024)
Fortune
"100 Fastest-Growing Companies" (2024)
"Small Business 100" (2009 and 2008)
Boston Business Journal "Top 150 Public Companies"
The Boston Globe's "The Globe 100" (2013-2006)
24/7 Wall Street's "100 Best Small Companies in America" (2012)
== References ==
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealth Care
industryHealth Care
employees4,846
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$603M2016-12-31 → 2025-12-31
EPS$8.752016-12-31 → 2025-12-31
Free Cash Flow·2016-12-31 → 2024-12-31
Net margin11.4%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | UFPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 32.45Y avg ≈28.5 | ≈28.5 | 37.3 | Undervalued | |
| P/S (TTM) | 3.75Y avg ≈2.9 | ≈2.9 | 2.0 | Overvalued | |
| P/B (MRQ) | 5.05Y avg ≈4.0 | ≈4.0 | 1.7 | Overvalued | |
| EV / EBITDA | 21.75Y avg ≈18.0 | ≈18.0 | 20.6 | Undervalued | |
| Price / Cash Flow | 25.15Y avg ≈33.6 | ≈33.6 | 18.9 | Fair value | |
| EV / Revenue | 4.05Y avg ≈3.2 | ≈3.2 | · | · | |
| Price / Tangible Book (MRQ) | 7.15Y avg ≈69.0 | ≈69.0 | · | · | |
| PEG Ratio | ≈0.9 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | UFPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 28.5%5Y avg ≈27.1% | ≈27.1% | 57.3% | Weak | |
| Operating Margin (TTM) | 15.3%5Y avg ≈14.3% | ≈14.3% | 8.1% | Top tier | |
| EBITDA Margin | 18.5%5Y avg ≈17.6% | ≈17.6% | 11.7% | Top tier | |
| Pretax Margin (TTM) | 14.0%5Y avg ≈13.4% | ≈13.4% | 6.1% | Top tier | |
| Net Profit Margin (TTM) | 11.4%5Y avg ≈10.8% | ≈10.8% | 3.8% | Top tier | |
| ROA (TTM) | 11.0%5Y avg ≈10.2% | ≈10.2% | -3.8% | Top tier | |
| ROE (TTM) | 17.1%5Y avg ≈15.4% | ≈15.4% | -5.8% | Top tier | |
| ROIC | 13.7%5Y avg ≈12.4% | ≈12.4% | -4.8% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | UFPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.35Y avg ≈0.3 | ≈0.3 | 0.5 | Low debt | |
| Current Ratio (MRQ) | 3.05Y avg ≈2.5 | ≈2.5 | 2.7 | In line | |
| Quick Ratio | 1.45Y avg ≈1.3 | ≈1.3 | 1.3 | Strong liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.25Y avg ≈0.3 | ≈0.3 | 0.6 | Low debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | UFPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 19.5%5Y avg ≈29.0% | ≈29.0% | · | · | |
| Revenue CAGR 3Y | 19.4%5Y avg ≈28.3% | ≈28.3% | · | · | |
| Revenue CAGR 5Y | 27.4% | · | · | · | |
| EPS YoY | 15.4%5Y avg ≈46.3% | ≈46.3% | · | · | |
| Net Income YoY | 15.8%5Y avg ≈47.3% | ≈47.3% | · | · | |
| EPS CAGR 3Y | 17.1%5Y avg ≈39.8% | ≈39.8% | · | · | |
| EPS CAGR 5Y | 37.7% | · | · | · | |
| Net Income CAGR 3Y | 17.8%5Y avg ≈40.8% | ≈40.8% | · | · | |
| Net Income CAGR 5Y | 38.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | UFPT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.95Y avg ≈0.9 | ≈0.9 | 0.5 | Top tier | |
| Inventory Turnover | 5.05Y avg ≈5.2 | ≈5.2 | 2.3 | Top tier | |
| Receivables Turnover | 7.25Y avg ≈6.9 | ≈6.9 | 6.4 | In line | |
| Revenue / Employee | ≈$124.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
6.8%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 3, 2026 | $2.92 | $2.54 | 14.7% |
| March 31, 2026 | $2.48 | $2.29 | 8.2% | |
| Dec. 31, 2025 | $2.25 | $2.13 | 5.5% | |
| Sept. 30, 2025 | $2.11 | $2.09 | 0.91% | |
| June 30, 2025 | $2.21 | $2.15 | 2.9% | |
| March 31, 2025 | $2.21 | $2.04 | 8.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $603M | $504M | $400M | $354M | $206M | $179M | $198M | $190M | $148M | $146M | $139M | $139M | |
| Cost of Revenue | $432M | $358M | $288M | $264M | $155M | $135M | $144M | $142M | $112M | $111M | $101M | $102M | |
| Gross Profit | $170M | $147M | $112M | $90M | $51M | $45M | $54M | $48M | $35M | $35M | $37M | $37M | |
| R&D Expense | $9M | $10M | $7M | $9M | $8M | $8M | $9M | $10M | $5M | $1M | $1M | $1M | |
| SG&A Expense | $77M | $62M | $51M | $46M | $29M | $27M | $29M | $28M | $24M | $24M | $24M | $24M | |
| Operating Income | $92M | $81M | $58M | $55M | $21M | $17M | $25M | $20M | $12M | $12M | $12M | $12M | |
| Interest Expense | · | $8M | $4M | $3M | $39.0K | $83.0K | $674.0K | $1M | $50.0K | $69.0K | $87.0K | $154.0K | |
| Interest Income | · | · | · | · | $49.0K | $0 | $0 | $47.0K | $216.0K | $149.0K | $114.0K | $46.0K | |
| Other Non-op | $-21.0K | $189.0K | $-117.0K | $81.0K | $26.0K | $-366.0K | $-388.0K | $64.0K | · | · | $27.0K | $312.0K | |
| Pretax Income | $83M | $73M | $54M | $53M | $21M | $16M | $24M | $18M | $12M | $12M | $12M | $12M | |
| Income Tax | $14M | $14M | $9M | $11M | $5M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | |
| Net Income | $68M | $59M | $45M | $42M | $16M | $13M | $20M | $14M | $9M | $8M | $8M | $8M | |
| EPS (Basic) | $8.87 | $7.69 | $5.89 | $5.52 | $2.11 | $1.79 | $2.66 | $1.95 | $1.27 | $1.11 | $1.07 | $1.08 | |
| EPS (Diluted) | $8.75 | $7.58 | $5.83 | $5.45 | $2.09 | $1.77 | $2.63 | $1.93 | $1.26 | $1.10 | $1.05 | $1.05 | |
| Shares (Basic) | 7,705,000 | 7,668,000 | 7,624,000 | 7,564,000 | 7,524,000 | 7,484,000 | 7,424,000 | 7,347,000 | 7,248,000 | 7,190,000 | 7,102,000 | 7,028,000 | |
| Shares (Diluted) | 7,804,000 | 7,785,000 | 7,701,000 | 7,663,000 | 7,615,000 | 7,568,000 | 7,516,000 | 7,430,000 | 7,337,000 | 7,275,000 | 7,206,000 | 7,175,000 | |
| EBITDA | $111M | $96M | $69M | $67M | $30M | $25M | $33M | $27M | $17M | $18M | · | $16M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $13M | $5M | $4M | $11M | $24M | $4M | $3M | $38M | $31M | $30M | $34M | |
| Receivables | $83M | $85M | $64M | $55M | $39M | $26M | $29M | $28M | $21M | $21M | $17M | $16M | |
| Inventory | $87M | $88M | $70M | $54M | $33M | $19M | $18M | $20M | $13M | $14M | $14M | $13M | |
| Prepaid Expense | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $930.0K | $664.0K | |
| Current Assets | $201M | $195M | $145M | $116M | $87M | $72M | $53M | $56M | $75M | $70M | $63M | $67M | |
| PP&E (Net) | $79M | $71M | $62M | $58M | $57M | $54M | $57M | $58M | $54M | $49M | $47M | $35M | |
| PP&E (Gross) | $152M | $135M | $119M | $111M | $127M | $118M | $116M | $112M | $107M | $97M | $91M | $76M | |
| Accum. Depreciation | $73M | $64M | $57M | $53M | $70M | $65M | $59M | $54M | $53M | $48M | $44M | $41M | |
| Goodwill | $197M | $190M | $113M | $113M | $108M | $52M | $52M | $52M | $7M | $7M | $7M | $7M | |
| Intangibles | $141M | $144M | $64M | $68M | $68M | $20M | $21M | $22M | · | $318.0K | $636.0K | $953.0K | |
| Other Non-current Assets | $3M | $447.0K | $469.0K | $4M | $1M | $153.0K | $147.0K | $201.0K | $144.0K | $153.0K | $2M | $2M | |
| Total Assets | $655M | $629M | $404M | $378M | $334M | $203M | $189M | $190M | $138M | $128M | $120M | $113M | |
| Accounts Payable | $24M | $24M | $22M | $20M | $11M | $4M | $5M | $7M | $4M | $4M | $5M | $5M | |
| Accrued Liabilities | $29M | $30M | $22M | $23M | $17M | $8M | $8M | $8M | $5M | $5M | $5M | $5M | |
| Current Liabilities | $75M | $76M | $58M | $56M | $39M | $15M | $17M | $21M | $10M | $10M | $11M | $12M | |
| Capital Leases | $14M | $12M | $11M | · | $7M | $950.0K | $2M | $0 | · | · | · | · | |
| Deferred Tax | $9M | $3M | $428.0K | $448.0K | $3M | $5M | $5M | $4M | $2M | $3M | $3M | $2M | |
| Other Non-current Liabilities | $4M | $11M | $15M | $18M | $15M | $1M | $334.0K | $24.0K | $82.0K | $184.0K | $171.0K | · | |
| Total Liabilities | $231M | $286M | $118M | $141M | $140M | $26M | $27M | $49M | $14M | $15M | $16M | $18M | |
| Long-term Debt | $135M | $189M | $32M | $55M | $75M | $0 | · | $25M | · | $856.0K | $2M | $3M | |
| Total Debt | $135M | $189M | $32M | $55M | $75M | · | · | $25M | · | $856.0K | · | $3M | |
| Common Stock | $77.0K | $77.0K | $76.0K | $76.0K | $75.0K | $75.0K | $74.0K | $74.0K | $73.0K | $72.0K | $72.0K | $71.0K | |
| Paid-in Capital | $46M | $41M | $39M | $36M | $34M | $32M | $31M | $29M | $27M | $25M | $24M | $22M | |
| Retained Earnings | $375M | $307M | $248M | $203M | $161M | $145M | $132M | $112M | $98M | $88M | $80M | $73M | |
| Treasury Stock | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | · | |
| AOCI | $4M | $-4M | $268.0K | $-610.0K | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $424M | $343M | $286M | $238M | $194M | $177M | $162M | $140M | $124M | $113M | $104M | $95M | |
| Liabilities + Equity | $655M | $629M | $404M | $378M | $334M | $203M | $189M | $190M | $138M | $128M | $120M | $113M | |
| Shares Outstanding | 7,676,785 | 7,676,785 | 7,639,780 | 7,639,780 | 7,581,685 | 7,500,066 | 7,446,209 | 7,385,443 | 7,280,350 | 7,212,464 | 7,140,818 | 7,068,815 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $19M | $15M | $11M | $12M | $8M | $8M | $8M | $8M | $6M | $6M | $5M | $4M | |
| Stock-based Comp | $9M | $7M | $5M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Deferred Tax | $5M | $1M | $823.0K | $-4M | $-2M | $136.0K | $792.0K | $2M | $-1M | $576.0K | $437.0K | $1M | |
| Amort. of Intangibles | $10M | $7M | $4M | $4M | $1M | $1M | $1M | $1M | $300.0K | $300.0K | $318.0K | $393.0K | |
| Restructuring | · | · | · | · | · | · | · | · | $63.0K | $420.0K | $2M | $2M | |
| Other Non-cash | $-10M | $-15M | $-20M | $-35M | $-11M | $1M | $924.0K | $-4M | $3M | $-6M | · | $-3M | |
| Operating Cash Flow | $92M | $67M | $41M | $18M | $14M | $25M | $31M | $21M | $17M | $9M | $13M | $11M | |
| CapEx | · | $10M | $10M | $14M | $5M | $4M | $6M | $5M | $10M | $7M | $16M | $13M | |
| Investing Cash Flow | $-28M | $-210M | $-10M | $1M | $-101M | $-4M | $-6M | $-82M | $-10M | $-7M | $-16M | · | |
| Debt Issued | $0 | $125M | $0 | $0 | $40M | $0 | $0 | $20M | · | · | · | · | |
| Net Debt Issued | $-12M | $90M | $-4M | $-4M | $40M | $0 | $-17M | $17M | $-856.0K | $-1M | · | $-977.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $587.0K | · | |
| Financing Cash Flow | $-58M | $152M | $-30M | $-26M | $74M | $-285.0K | $-25M | $26M | $-475.0K | $-559.0K | $-1M | · | |
| Net Change in Cash | $7M | $8M | $812.0K | $-7M | $-13M | $20M | $505.0K | $-35M | $7M | $2M | $-4M | · | |
| Taxes Paid | $4M | $13M | $11M | $13M | $6M | $2M | $1M | $3M | $4M | $4M | $1M | $3M | |
| Free Cash Flow | · | $57M | $31M | $4M | $9M | $21M | $25M | $16M | $7M | $2M | · | $-2M | |
| Levered FCF | · | $50M | $28M | $2M | $9M | $21M | $25M | $15M | $7M | $2M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.3% | 29.1% | 28.1% | 25.5% | 24.8% | 24.9% | 27.2% | 25.4% | 24.0% | 23.7% | · | 26.5% | |
| Operating Margin | 15.3% | 16.0% | 14.4% | 15.7% | 10.3% | 9.3% | 12.4% | 10.3% | 7.9% | 8.4% | · | 8.3% | |
| Net Margin | 11.3% | 11.7% | 11.2% | 11.8% | 7.7% | 7.4% | 10.0% | 7.5% | 6.2% | 5.5% | · | 5.4% | |
| Pretax Margin | 13.7% | 14.5% | 13.5% | 14.9% | 10.3% | 9.1% | 11.9% | 9.7% | 8.0% | 8.4% | · | 8.5% | |
| EBITDA Margin | 18.5% | 18.9% | 17.3% | 19.0% | 14.4% | 13.9% | 16.6% | 14.4% | 11.7% | 12.2% | · | 11.4% | |
| ROA | 10.6% | 11.4% | 11.5% | 11.7% | 5.9% | 6.8% | 10.4% | 8.7% | 6.9% | 6.4% | · | 6.9% | |
| ROE | 16.9% | 17.6% | 16.1% | 18.0% | 8.2% | 7.6% | 12.4% | 10.4% | 7.8% | 7.4% | · | 8.4% | |
| ROIC | 13.7% | 12.3% | 15.1% | 15.0% | 5.9% | 7.8% | 12.7% | 9.2% | 7.3% | 7.0% | · | 7.6% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.6 | 2.5 | 2.1 | 2.5 | 4.7 | 3.3 | 2.7 | 7.6 | 7.3 | · | 5.9 | |
| Quick Ratio | 1.4 | 1.3 | 1.2 | 1.1 | 1.5 | 3.3 | 2.0 | 1.5 | 6.0 | 5.5 | · | 4.4 | |
| Debt / Equity | 0.3 | 0.6 | 0.1 | 0.2 | 0.4 | · | · | 0.2 | · | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.3 | 0.5 | 0.1 | 0.2 | 0.4 | · | · | 0.2 | · | · | · | 0.0 | |
| Interest Coverage | · | 10.0 | 15.8 | 20.1 | 241.1 | 201.6 | 36.7 | 14.9 | 233.9 | 177.3 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.0 | 1.0 | 1.0 | 0.8 | 0.9 | 1.0 | 1.2 | 1.1 | 1.2 | · | 1.3 | |
| Inventory Turnover | 5.0 | 4.5 | 4.7 | 6.1 | 6.0 | 7.3 | 7.6 | 8.8 | 8.3 | 7.9 | · | 8.6 | |
| Receivables Turnover | 7.2 | 6.8 | 6.7 | 7.5 | 6.3 | 6.5 | 7.0 | 7.7 | 6.9 | 7.5 | · | 8.3 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $54.95 | $44.65 | · | $31.33 | $25.81 | $23.59 | $21.75 | $19.02 | $17.08 | $15.67 | · | $13.44 | |
| Revenue / Share | $77.24 | $64.79 | $51.95 | $46.17 | $27.09 | $23.70 | $26.39 | $25.63 | $20.15 | $20.09 | · | $19.42 | |
| Cash Flow / Share | $11.78 | $8.55 | $5.37 | $2.32 | $1.88 | $3.31 | $4.16 | $2.87 | $2.38 | $1.29 | · | $1.55 | |
| Cash / Share | $2.63 | $1.75 | · | $0.59 | $1.48 | $3.23 | $0.50 | $0.44 | $5.24 | $4.35 | · | $4.82 | |
| EPS (TTM) | $8.75 | $7.58 | $5.83 | $5.45 | $2.09 | $1.77 | $2.63 | $1.93 | $1.26 | $1.10 | $1.05 | $1.05 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.5% | 26.1% | 13.1% | 71.5% | 15.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 19.4% | 34.7% | 30.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 27.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 15.4% | 30.0% | 7.0% | 160.8% | 18.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 17.1% | 53.6% | 48.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 37.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 15.8% | 31.3% | 7.5% | 163.1% | 18.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 17.8% | 54.9% | 49.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 38.6% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $603M | $504M | $400M | $354M | $206M | $179M | $198M | $190M | $148M | $146M | $139M | $139M | |
| Net Income TTM | $68M | $59M | $45M | $42M | $16M | $13M | $20M | $14M | $9M | $8M | $8M | $8M | |
| Market Cap | $1.71B | $1.88B | · | $894M | $529M | $350M | $369M | $222M | $201M | $184M | · | $174M | |
| Enterprise Value | $1.83B | $2.05B | · | $944M | $593M | · | · | $244M | · | $153M | · | $143M | |
| P/E | 25.4 | 32.3 | 29.5 | 21.6 | 33.6 | 26.3 | 18.9 | 15.6 | 22.1 | 23.1 | 22.7 | 23.4 | |
| P/S | 2.8 | 3.7 | · | 2.5 | 2.6 | 1.9 | 1.9 | 1.2 | 1.4 | 1.3 | · | 1.2 | |
| P/B | 4.0 | 5.5 | · | 3.8 | 2.7 | 2.0 | 2.3 | 1.6 | 1.6 | 1.6 | · | 1.8 | |
| P / Tangible Book | 20.0 | 212.1 | · | 15.9 | 27.9 | 3.3 | · | · | · | · | · | · | |
| P / Cash Flow | 18.6 | 28.2 | · | 50.4 | 37.0 | 14.0 | 11.8 | 10.4 | 11.5 | 19.5 | · | 15.6 | |
| P / FCF | · | 33.0 | · | 225.5 | 59.5 | 16.9 | 14.5 | 14.0 | 28.4 | 87.4 | · | -75.2 | |
| EV / EBITDA | 16.4 | 21.5 | · | 14.0 | 20.0 | · | · | 8.9 | · | 8.6 | · | 8.9 | |
| EV / FCF | · | 36.1 | · | 238.2 | 66.7 | · | · | 15.3 | · | 72.9 | · | -61.7 | |
| EV / Revenue | 3.0 | 4.1 | · | 2.7 | 2.9 | · | · | 1.3 | · | 1.0 | · | 1.0 | |
| Earnings Yield | 3.9% | 3.1% | 3.4% | 4.6% | 3.0% | 3.8% | 5.3% | 6.4% | 4.5% | 4.3% | 4.4% | 4.3% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $174M | $154M | $149M | $155M | $151M | $148M | $144M | $145M | $110M | $105M | $101M | $101M | $100M | $98M | $91M | $97M | |
| Cost of Revenue | $123M | $110M | $107M | $112M | $108M | $106M | $102M | $104M | $77M | $75M | $75M | $73M | $70M | $69M | $68M | $71M | |
| Gross Profit | $51M | $44M | $42M | $43M | $44M | $42M | $42M | $42M | $33M | $30M | $26M | $28M | $30M | $29M | $23M | $26M | |
| SG&A Expense | $23M | $21M | $21M | $19M | $19M | $19M | $19M | $16M | $14M | $14M | $13M | $12M | $12M | $13M | $12M | $12M | |
| Operating Income | $28M | $23M | $22M | $23M | $24M | $23M | $22M | $25M | $18M | $16M | $13M | $15M | $17M | $13M | $11M | $26M | |
| Interest Expense | · | · | · | · | $3M | $3M | · | $3M | $577.0K | $631.0K | · | $933.0K | $1M | $869.0K | $873.0K | $830.0K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $11.0K | |
| Other Non-op | $40.0K | $-22.0K | $-31.0K | $78.0K | $-32.0K | $-36.0K | $219.0K | $-70.0K | $-2.0K | $42.0K | $-89.0K | $29.0K | $20.0K | $-77.0K | $-232.0K | $104.0K | |
| Pretax Income | $26M | $22M | $20M | $21M | $22M | $20M | $19M | $21M | $17M | $15M | $12M | $14M | $16M | $12M | $10M | $25M | |
| Income Tax | $6M | $4M | $2M | $5M | $4M | $3M | $3M | $5M | $4M | $3M | $285.0K | $2M | $4M | $2M | $1M | $6M | |
| Net Income | $21M | $17M | $18M | $16M | $17M | $17M | $16M | $16M | $14M | $13M | $12M | $12M | $12M | $10M | $8M | $20M | |
| EPS (Basic) | $2.69 | $2.27 | $2.28 | $2.12 | $2.23 | $2.24 | $2.13 | $2.13 | $1.77 | $1.66 | $1.52 | $1.53 | $1.56 | $1.28 | $1.12 | $2.58 | |
| EPS (Diluted) | $2.68 | $2.24 | $2.25 | $2.11 | $2.21 | $2.21 | $2.10 | $2.11 | $1.75 | $1.64 | $1.51 | $1.52 | $1.55 | $1.27 | $1.10 | $2.56 | |
| Shares (Basic) | 7,740,000 | 7,721,000 | · | 7,712,000 | 7,709,000 | 7,688,000 | · | 7,674,000 | 7,672,000 | 7,651,000 | · | 7,639,000 | 7,625,000 | 7,592,000 | · | 7,570,000 | |
| Shares (Diluted) | 7,788,000 | 7,799,000 | · | 7,780,000 | 7,773,000 | 7,776,000 | · | 7,772,000 | 7,753,000 | 7,737,000 | · | 7,709,000 | 7,690,000 | 7,681,000 | · | 7,638,000 | |
| EBITDA | · | $23M | · | $23M | $29M | $28M | · | $25M | $18M | $19M | · | $15M | $17M | $16M | · | $26M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $20M | $20M | $18M | $15M | $14M | $13M | $16M | $17M | $11M | · | $6M | $5M | $7M | · | $10M | |
| Receivables | $113M | $99M | $83M | $85M | $85M | $94M | $85M | $89M | $61M | $61M | · | $61M | $64M | $60M | · | $61M | |
| Inventory | $100M | $94M | $87M | $86M | $85M | $90M | $88M | $89M | $78M | $74M | · | $70M | $63M | $57M | · | $54M | |
| Prepaid Expense | $8M | $8M | $6M | $7M | $5M | $5M | $4M | $5M | $4M | $4M | · | $3M | $5M | $4M | · | $2M | |
| Current Assets | $235M | $224M | $201M | $198M | $191M | $206M | $195M | $201M | $162M | $151M | · | $140M | $137M | $127M | · | $130M | |
| PP&E (Net) | $77M | $78M | $79M | $78M | $74M | $72M | $71M | $70M | $64M | $62M | · | $61M | $60M | $59M | · | $56M | |
| PP&E (Gross) | $155M | $154M | $152M | $149M | $143M | $138M | $135M | $133M | $125M | $121M | · | $118M | $116M | $113M | · | $108M | |
| Accum. Depreciation | $78M | $76M | $73M | $71M | $69M | $67M | $64M | $63M | $61M | $59M | · | $57M | $56M | $54M | · | $51M | |
| Goodwill | $196M | $197M | $197M | $197M | $193M | $191M | $190M | $205M | $116M | $113M | $113M | $113M | $113M | $113M | $113M | $113M | |
| Intangibles | $135M | $138M | $141M | $143M | $142M | $143M | $144M | $135M | $62M | $63M | · | $65M | $66M | $67M | · | $69M | |
| Other Non-current Assets | $5M | $5M | $3M | $3M | $3M | $3M | $447.0K | $436.0K | $414.0K | $413.0K | · | $633.0K | $858.0K | $4M | · | $4M | |
| Total Assets | $682M | $675M | $655M | $653M | $635M | $643M | $629M | $639M | $422M | $408M | · | $400M | $398M | $391M | · | $388M | |
| Accounts Payable | $33M | $28M | $24M | $29M | $23M | $30M | $24M | $26M | $23M | $24M | · | $27M | $25M | $20M | · | $21M | |
| Accrued Liabilities | $23M | $26M | $29M | $30M | $25M | $29M | $30M | $30M | $21M | $16M | · | $19M | $17M | $17M | · | $26M | |
| Current Liabilities | $78M | $77M | $75M | $82M | $69M | $80M | $76M | $78M | $52M | $52M | · | $57M | $53M | $52M | · | $57M | |
| Capital Leases | $14M | $13M | $14M | $14M | $13M | $12M | $12M | $12M | $9M | · | · | · | · | · | · | $10M | |
| Deferred Tax | $14M | $12M | $9M | $8M | $5M | $5M | $3M | $2M | $182.0K | $575.0K | · | $443.0K | $458.0K | $0 | · | $4M | |
| Other Non-current Liabilities | $2M | $2M | $4M | $4M | $4M | $9M | $11M | $11M | $10M | $14M | · | $15M | $15M | $19M | · | $20M | |
| Total Liabilities | $219M | $236M | $231M | $249M | $249M | $282M | $286M | $309M | $112M | $113M | · | $127M | $138M | $144M | · | $162M | |
| Long-term Debt | $117M | $138M | $135M | $146M | $164M | $183M | $189M | $212M | $35M | $34M | · | $43M | $57M | $60M | · | $71M | |
| Total Debt | · | $138M | · | $146M | $164M | $183M | · | $212M | $35M | $34M | · | $43M | $57M | $60M | · | $71M | |
| Common Stock | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | $77.0K | · | $76.0K | $76.0K | $76.0K | · | $76.0K | |
| Paid-in Capital | $48M | $45M | $46M | $44M | $42M | $39M | $41M | $39M | $37M | $36M | · | $38M | $37M | $35M | · | $35M | |
| Retained Earnings | $413M | $392M | $375M | $357M | $341M | $324M | $307M | $290M | $274M | $260M | · | $236M | $224M | $212M | · | $194M | |
| Treasury Stock | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | $587.0K | · | $587.0K | $587.0K | $587.0K | · | $587.0K | |
| AOCI | $2M | $2M | $4M | $4M | $3M | $-2M | $-4M | $573.0K | $-497.0K | $-316.0K | · | $-869.0K | $-76.0K | $-117.0K | · | $-3M | |
| Stockholders' Equity | $462M | $439M | $424M | $404M | $385M | $361M | $343M | $329M | $310M | $295M | $286M | $272M | $260M | $246M | $238M | $226M | |
| Liabilities + Equity | $682M | $675M | $655M | $653M | $635M | $643M | $629M | $639M | $422M | $408M | · | $400M | $398M | $391M | · | $388M | |
| Shares Outstanding | 7,745,790 | 7,736,939 | 7,713,300 | 7,712,444 | · | 7,706,825 | 7,676,785 | 7,674,363 | 7,674,363 | 7,670,487 | · | 7,638,812 | 7,638,812 | 7,612,970 | · | 7,578,605 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $5M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $838.0K | $897.0K | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | $798.0K | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-cash | · | · | · | · | · | $-10M | · | · | · | $-7M | · | · | · | $-12M | · | · | |
| Operating Cash Flow | $16M | $3M | $17M | $36M | $25M | $14M | $24M | $20M | $12M | $11M | $13M | $18M | $9M | $2M | $18M | $-109.0K | |
| CapEx | · | · | · | · | $3M | $3M | · | $2M | $3M | $2M | · | $3M | $3M | $2M | $3M | $2M | |
| Investing Cash Flow | $-1M | $-2M | $-4M | $-15M | $-6M | $-3M | $-4M | $-197M | $-7M | $-2M | $-3M | $-3M | $-3M | $-2M | $-3M | $33M | |
| Debt Issued | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | · | · | · | · | |
| Net Debt Issued | · | $-3M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | $-1M | · | · | |
| Financing Cash Flow | $-25M | $-2M | $-11M | $-17M | $-19M | $-11M | $-23M | $177M | $1M | $-3M | $-11M | $-14M | $-7M | $3M | $-21M | $-29M | |
| Net Change in Cash | $-11M | $-325.0K | $2M | $3M | $864.0K | $578.0K | $-3M | $-372.0K | $5M | $6M | $-1M | $1M | $-1M | $2M | $-5M | $4M | |
| Taxes Paid | $3M | $10.0K | $2M | $686.0K | $1M | $-468.0K | $3M | $4M | $6M | $0 | $394.0K | $2M | $8M | $-50.0K | $885.0K | $7M | |
| Free Cash Flow | · | · | · | · | · | $11M | · | · | · | $9M | · | · | · | $-456.0K | · | · | |
| Levered FCF | · | · | · | · | · | $9M | · | · | · | $8M | · | · | · | $-1M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 28.8% | · | 27.7% | 28.8% | 28.4% | · | 28.6% | 30.0% | 28.6% | · | 27.5% | 29.6% | 29.4% | · | 26.3% | |
| Operating Margin | · | 15.2% | · | 15.1% | 16.1% | 15.6% | · | 17.1% | 16.3% | 15.2% | · | 14.9% | 17.0% | 13.1% | · | 26.8% | |
| Net Margin | · | 11.3% | · | 10.6% | 11.4% | 11.6% | · | 11.3% | 12.3% | 12.1% | · | 11.6% | 11.9% | 10.0% | · | 20.2% | |
| Pretax Margin | · | 14.0% | · | 13.6% | 14.3% | 13.7% | · | 14.6% | 15.8% | 14.6% | · | 14.0% | 16.0% | 12.2% | · | 26.0% | |
| EBITDA Margin | · | 15.2% | · | 15.1% | 19.2% | 18.7% | · | 17.1% | 16.3% | 18.0% | · | 14.9% | 17.0% | 16.0% | · | 26.8% | |
| ROA | · | 2.7% | · | 2.5% | 3.2% | 3.3% | · | 3.1% | 3.3% | 3.2% | · | 3.0% | 3.0% | 2.6% | · | 6.4% | |
| ROE | · | 4.4% | · | 4.5% | 4.9% | 5.2% | · | 5.4% | 4.8% | 4.7% | · | 4.7% | 5.1% | 4.4% | · | 9.4% | |
| ROIC | · | 3.3% | · | 3.3% | 3.5% | 3.6% | · | 3.5% | 4.0% | 4.0% | · | 3.9% | 4.0% | 3.4% | · | 6.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.9 | · | 2.4 | 2.8 | 2.6 | · | 2.6 | 3.1 | 2.9 | · | 2.5 | 2.6 | 2.4 | · | 2.3 | |
| Quick Ratio | · | 1.5 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.5 | 1.4 | · | 1.2 | 1.3 | 1.3 | · | 1.2 | |
| Debt / Equity | · | 0.3 | · | 0.4 | 0.4 | 0.5 | · | 0.6 | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| LT Debt / Equity | · | 0.3 | · | 0.3 | 0.4 | 0.5 | · | 0.6 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.3 | |
| Interest Coverage | · | · | · | · | 9.1 | 8.2 | · | 7.1 | 31.1 | 25.2 | · | 16.1 | 15.6 | 14.8 | · | 30.9 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | · | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.1 | 1.1 | · | 1.2 | 1.2 | 1.4 | · | 1.9 | |
| Receivables Turnover | · | 1.6 | · | 1.8 | 2.1 | 1.9 | · | 1.9 | 1.8 | 1.7 | · | 1.6 | 1.6 | 1.8 | · | 2.1 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $56.72 | · | $52.37 | · | $46.80 | · | $42.89 | $40.42 | $38.46 | · | $35.66 | $34.07 | $32.38 | · | $29.84 | |
| Revenue / Share | · | $19.77 | · | $19.87 | $19.45 | $19.05 | · | $18.68 | $14.21 | $13.57 | · | $13.07 | $13.01 | $12.73 | · | $12.70 | |
| Cash Flow / Share | · | $0.41 | · | · | · | $1.78 | · | · | · | $1.38 | · | · | · | $0.22 | · | · | |
| Cash / Share | · | $2.58 | · | $2.36 | · | $1.82 | · | $2.13 | $2.18 | $1.48 | · | $0.83 | $0.69 | $0.85 | · | $1.31 | |
| EPS (TTM) | $9.28 | $8.81 | · | $8.63 | $8.63 | $8.17 | · | $7.01 | $6.42 | $6.22 | · | $5.44 | $6.48 | $6.10 | · | $4.79 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $632M | $609M | · | $598M | $589M | $548M | · | $462M | $417M | $407M | · | $390M | $386M | $380M | · | $319M | |
| Net Income TTM | $72M | $69M | · | $67M | $67M | $63M | · | $54M | $50M | $48M | · | $42M | $50M | $47M | · | $37M | |
| Market Cap | · | $1.50B | · | $1.54B | · | $1.55B | · | $2.43B | $2.03B | $1.93B | · | $1.23B | $1.48B | $988M | · | $651M | |
| Enterprise Value | · | $1.62B | · | $1.67B | · | $1.72B | · | $2.63B | $2.04B | $1.96B | · | $1.27B | $1.53B | $1.04B | · | $712M | |
| P/E | 28.6 | 22.0 | · | 23.1 | 28.3 | 24.7 | · | 45.2 | 41.1 | 40.5 | · | 29.7 | 29.9 | 21.3 | · | 17.9 | |
| P/S | · | 2.5 | · | 2.6 | · | 2.8 | · | 5.3 | 4.9 | 4.7 | · | 3.2 | 3.8 | 2.6 | · | 2.0 | |
| P/B | · | 3.4 | · | 3.8 | · | 4.3 | · | 7.4 | 6.5 | 6.6 | · | 4.5 | 5.7 | 4.0 | · | 2.9 | |
| P / Tangible Book | 15.7 | 14.4 | · | 24.3 | · | 56.6 | · | · | 15.3 | 16.3 | · | 13.1 | 18.3 | 15.0 | · | 14.6 | |
| P / Cash Flow | · | 467.5 | · | · | · | 112.6 | · | · | · | 181.6 | · | · | · | 573.7 | · | · | |
| EV / Revenue | · | 2.7 | · | 2.8 | · | 3.1 | · | 5.7 | 4.9 | 4.8 | · | 3.3 | 4.0 | 2.7 | · | 2.2 | |
| Earnings Yield | 3.5% | 4.5% | · | 4.3% | 3.5% | 4.0% | · | 2.2% | 2.4% | 2.5% | · | 3.4% | 3.3% | 4.7% | · | 5.6% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $603M | $504M | $400M | $354M | $206M |
| Gross Margin % | 28.3% | 29.1% | 28.1% | 25.5% | 24.8% |
| Operating Margin % | 15.3% | 16.0% | 14.4% | 15.7% | 10.3% |
| Net Income | $68M | $59M | $45M | $42M | $16M |
| Diluted EPS | $8.75 | $7.58 | $5.83 | $5.45 | $2.09 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.3 | 0.6 | 0.1 | 0.2 | 0.4 |
| Current Ratio | 2.7 | 2.6 | 2.5 | 2.1 | 2.5 |
| Quick Ratio | 1.4 | 1.3 | 1.2 | 1.1 | 1.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $57M | $31M | $4M | $9M |
Institutional owners (13F) 296 filers · $2.4B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
296
Value held
$2.4B
New positions
39
Exited positions
32
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 39 (-3 vs prior Q) | 32 (+3 vs prior Q) | 94 (-1 vs prior Q) | 93 (+6 vs prior Q) | -53K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $302,622,035 | 1,141,410 | 12.43% | Shares |
| CONGRESS ASSET MANAGEMENT CO | $182,260,702 | 687,439 | 7.49% | Shares |
| WASATCH ADVISORS LP | $150,487,797 | 777,313 | 6.18% | Shares |
| NEUBERGER BERMAN GROUP LLC | $142,384,885 | 537,038 | 5.85% | Shares |
| VANGUARD GROUP INC | $118,470,323 | 533,578 | 4.87% | Shares |
| Boston Trust Walden Corp | $89,157,386 | 336,278 | 3.66% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $87,392,946 | 329,623 | 3.59% | Shares |
| STATE STREET CORP | $82,935,580 | 312,811 | 3.41% | Shares |
| AMERICAN CENTURY COMPANIES INC | $74,230,610 | 279,976 | 3.05% | Shares |
| UBS Group AG | $67,539,216 | 254,740 | 2.77% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $59,249,662 | 223,474 | 2.43% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $53,284,151 | 200,933 | 2.19% | Shares |
| Allspring Global Investments Holdings, LLC | $52,584,093 | 195,720 | 2.16% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $49,396,356 | 186,313 | 2.03% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $42,743,728 | 161,218 | 1.76% | Shares |
| AltraVue Capital, LLC | $39,097,647 | 147,466 | 1.61% | Shares |
| MORGAN STANLEY | $32,979,085 | 124,387 | 1.35% | Shares |
| FRANKLIN RESOURCES INC | $30,242,848 | 114,068 | 1.24% | Shares |
| Swedbank AB | $27,972,541 | 105,505 | 1.15% | Shares |
| ASHFORD CAPITAL MANAGEMENT INC | $27,843,953 | 105,020 | 1.14% | Shares |
| GENEVA CAPITAL MANAGEMENT LLC | $27,318,401 | 103,038 | 1.12% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $26,074,607 | 98,347 | 1.07% | Shares |
| Annex Advisory Services, LLC | $25,244,182 | 130,394 | 1.04% | Shares |
| NORTHERN TRUST CORP | $24,195,763 | 91,260 | 0.99% | Shares |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | $22,423,370 | 84,575 | 0.92% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $22,394,205 | 84,465 | 0.92% | Shares |
| Owls Nest Partners IA, LLC | $19,813,430 | 74,731 | 0.81% | Shares |
| De Lisle Partners LLP | $19,677,115 | 74,302 | 0.81% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19,428,461 | 73,279 | 0.80% | Shares |
| ROYAL BANK OF CANADA | $18,066,000 | 68,136 | 0.74% | Shares |
| BANK OF AMERICA CORP /DE/ | $15,990,521 | 60,312 | 0.66% | Shares |
| OSAIC HOLDINGS, INC. | $15,515,929 | 58,522 | 0.64% | Shares |
| Impax Asset Management Group plc | $14,714,715 | 55,500 | 0.60% | Shares |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $14,628,813 | 55,176 | 0.60% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $14,582,150 | 55,000 | 0.60% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $14,197,712 | 53,550 | 0.58% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $13,647,567 | 51,475 | 0.56% | Shares |
| BROWN CAPITAL MANAGEMENT LLC | $13,439,175 | 50,689 | 0.55% | Shares |
| Applied Fundamental Research, LLC | $13,388,535 | 50,498 | 0.55% | Shares |
| Rockefeller Capital Management L.P. | $12,274,193 | 46,295 | 0.50% | Shares |
| RAYMOND JAMES FINANCIAL INC | $12,209,501 | 46,051 | 0.50% | Shares |
| ROYCE & ASSOCIATES LP | $11,789,005 | 44,465 | 0.48% | Shares |
| SEI INVESTMENTS CO | $11,715,364 | 44,185 | 0.48% | Shares |
| Bank of New York Mellon Corp | $11,321,581 | 42,702 | 0.47% | Shares |
| Congress Wealth Management LLC / DE / | $11,267,249 | 46,147 | 0.46% | Shares |
| Palisades Investment Partners, LLC | $10,293,937 | 38,826 | 0.42% | Shares |
| RENAISSANCE GROUP LLC | $9,895,447 | 37,323 | 0.41% | Shares |
| Ranger Investment Management, L.P. | $9,552,634 | 36,030 | 0.39% | Shares |
| Legato Capital Management LLC | $9,359,354 | 35,301 | 0.38% | Shares |
| RICE HALL JAMES & ASSOCIATES, LLC | $9,023,434 | 34,034 | 0.37% | Shares |
Activists & 5%+ owners 9 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Ancora Advisors, LLC ×4 filings | April 4, 2019 | · | Initial filing | · | SEC |
| Thomas E. Lynch, Scott P. Scharfman, Mill Road Capital II GP LLC, Mill Road Capital II, L.P. | Sept. 19, 2016 | · | Initial filing | · | SEC |
| Mill Road Capital II, L.P., Mill Road Capital II GP LLC, Thomas E. Lynch, Scott P. Scharfman | Feb. 19, 2016 | · | Initial filing | Passive investment | SEC |
| Nantahala Capital Management, LLC (2) | July 25, 2011 | · | Initial filing | · | SEC |
| Boston Avenue Capital, LLC, Yorktown Avenue Capital, LLC, Value Fund Advisors, LLC, Charles M. Gillman ×2 filings | March 13, 2007 | · | Initial filing | Passive investment | SEC |
| Yorktown Avenue Capital, LLC, Value Fund Advisors, LLC, Charles M. Gillman | May 15, 2006 | · | Initial filing | Passive investment | SEC |
| R. Jeffrey Bailly ×2 filings | March 24, 2006 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Feb. 26, 2001 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Feb. 14, 2001 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 28 insiders · 7 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Ronald J Lataille | Chief Financial Officer | June 4, 2026 A | 20,352 | 0 | 0 | $0 |
| Mitchell Rock | President | June 4, 2026 A | 39,115 | 0 | 0 | $0 |
| Jeffrey R Bailly | Executive Chairman | Aug. 10, 2026 S | 0 | 0 | 7 | $-9,110,272 |
| Jason Holt | Vice President | Aug. 6, 2026 S | 7,878 | 0 | 2 | $-370,058 |
| Ryan K Stafford | SVP Human Resources | June 4, 2026 A | 1,448 | 0 | 0 | $0 |
| Christopher P. Litterio | Senior Vice President | March 2, 2026 F | 11,977 | 0 | 10 | $-415,550 |
| Steve Cardin | Vice President | March 3, 2025 F | 5,623 | 0 | 0 | $0 |
| Marc D Kozin | Director | Aug. 25, 2026 S | 21,112 | 0 | 2 | $-2,131,474 |
| Symeria Hudson | Director | Aug. 18, 2026 S | 927 | 0 | 2 | $-720,236 |
| Cynthia L Feldmann | Director | Aug. 13, 2026 S | 4,476 | 0 | 3 | $-611,409 |
| Joseph John Hassett | Director | June 4, 2026 A | 2,425 | 0 | 0 | $0 |
| Thomas Oberdorf | Director | June 4, 2026 A | 13,219 | 0 | 0 | $0 |
| Daniel C Croteau | Director | June 4, 2026 A | 1,657 | 0 | 1 | $-634,977 |
| Robert W Pierce Jr | · | June 9, 2021 A | 63,518 | 0 | 0 | $0 |
| Lucia Luce Quinn | · | June 9, 2021 A | 6,086 | 0 | 0 | $0 |
| Daniel J Shaw | · | March 1, 2021 F | 12,090 | 0 | 0 | $0 |
| David W Smith | · | March 2, 2020 F | 17,829 | 0 | 0 | $0 |
| David K Stevenson | · | May 5, 2017 M | 18,103 | 0 | 0 | $0 |
| Kenneth L Gestal | · | Nov. 23, 2015 M | 3,329 | 0 | 0 | $0 |
| David Bartlett Gould | · | May 6, 2015 M | 58,506 | 0 | 0 | $0 |
| Richard Lesavoy | · | May 14, 2013 S | 103,426 | 0 | 0 | $0 |
| Richard L Bailly | · | June 8, 2011 A | 19,734 | 0 | 0 | $0 |
| Michael John Ross | · | June 4, 2008 A | · | 0 | 0 | $0 |
| Yorktown Avenue Capital, LLC | · | Nov. 27, 2006 P | 171,153 | 0 | 0 | $0 |
| William Shaw | · | Aug. 17, 2006 S | 288,924 | 0 | 0 | $0 |
| WORRELL PETER R | · | June 8, 2006 A | 0 | 0 | 0 | $0 |
| William C Curry | · | May 16, 2006 M | 7,252 | 0 | 0 | $0 |
| Wayne G Williams | · | May 16, 2005 A | 53,731 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 43 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| CSMD · Professionally Managed Portfolios | 2.63% | 46,829 NS | July 31, 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1.25% | 7,355 SH | Oct. 2, 2026 | Daily |
| RZG · Invesco Exchange-Traded Fund Trust | 0.59% | 2,372 SH | Oct. 2, 2026 | Daily |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.38% | 19,485 NS | July 31, 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.23% | 5,394 NS | July 31, 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.22% | 9,209 SH | Aug. 19, 2026 | Daily |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.16% | 1,249 SH | Oct. 2, 2026 | Daily |
| IWO · iShares Trust | 0.14% | 71,575 SH | Sept. 11, 2026 | Daily |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.12% | 6,581 NS | July 31, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.12% | 8,178 SH | Aug. 19, 2026 | Daily |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.11% | 27,070 SH | Aug. 19, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.09% | 794 SH | Oct. 2, 2026 | Daily |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.08% | 1,765 NS | July 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.08% | 2,098 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.07% | 2,445 SH | Sept. 11, 2026 | Daily |
| IWM · iShares Trust | 0.07% | 195,393 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.06% | 3,651 NS | July 31, 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0.06% | 29 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 43,885 SH | Aug. 19, 2026 | Daily |
| RILA · Spinnaker ETF Series | 0.06% | 92 NS | July 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.06% | 5,810 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.05% | 4,798 SH | Oct. 2, 2026 | Daily |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.04% | 2,900 SH | Oct. 2, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.04% | 24,396 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.03% | 22,024 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 3,446 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.02% | 503 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 88,733 SH | Aug. 19, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.01% | 290 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 17,693 NS | July 31, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.01% | 4,860 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 668 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 844 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 1,656 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 2,373 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 9,801 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 2,031 SH | Sept. 9, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 233,328 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 624 SH | Aug. 19, 2026 | Daily |
| IJR · iShares Trust | · | 472,245 SH | Sept. 10, 2026 | Daily |
| IJT · iShares Trust | · | 73,060 SH | Sept. 9, 2026 | Daily |
| XJR · iShares Trust | · | 1,074 SH | Aug. 31, 2026 | Daily |
| ISCB · iShares Trust | · | 349 SH | Sept. 11, 2026 | Daily |
UFPT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$355.00
+18.1%
2 20.0%
Strong Buy
5 50.0%
Buy
3 30.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-28Mean target $355.00 +18.1%
← Below all targets
Current price $300.70
Low$350.00
Mean$355.00
High$360.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| STAA | $1.17B | -14.6 | -23.7% | -33.6% | -23.6% | 76.2% |
| BVS | · | 22.5 | -0.91% | 4.0% | 13.7% | 68.3% |
| KIDS | $446M | -10.5 | 15.4% | -16.8% | -11.3% | 73.0% |
| CERS | $396M | -25.8 | 16.1% | -6.7% | -26.0% | · |
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026